C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial

Authors: Charles L. Raison, Cynthia Siu, Andrei Pikalov, Michael Tocco, Antony Loebel

Journal: Brain Behavior and Immunity

Year Published: 2019

This study sought to investigate associations between levels of high-sensitivity c-reactive protein (hsCRP) prior to treatment and change in depressive symptoms and cognition in a short-term, double-blind, placebo-controlled study of lurasidone in children and adolescents with […]

Back to Publications